1. Tashkent State Medical University Repository
  2. Article and Thesis
Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/3734
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAbilov P.M., Makhkamova F.T.-
dc.date.accessioned2026-04-20T09:59:35Z-
dc.date.available2026-04-20T09:59:35Z-
dc.date.issued2025-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/3734-
dc.description.abstractAn outbreak of acute community acquired atypical pneumonia of unknown etiology was reported in Wuhan, the capital of Hubei Province in central China, in December 2019. The pathogen, which turned out to be a new coronavirus, had not previously been detected in human papillomaviruses and was named SARS CoV-2. On March 11, 2020, the WHO recognized the NCI epidemic as a pandemic. SARS-CoV-2 belongs to the genus Betacoronavirus family Coronaviridae .en_US
dc.language.isoen_USen_US
dc.publisherO'zbekiston, Toshkent ( Stomatologiya ) jurnalen_US
dc.relation.ispartofseriesUDC;616.994.41-006.6-018.1:616.19-002-
dc.titleINTERLEUKIN LEVELS IN THE PATHOGENESIS OF CORONAVIRUS INFECTION (COVID-19) AND THE EFFECT OF A NEW COMBINATION DRUG (G. LUCIDUM AND ALKHADAYA) ON THE COURSE AND PROGNOSIS OF THE DISEASEen_US
dc.typeArticleen_US
Appears in Collections:

Files in This Item:
File Description SizeFormat 
10_INTERLEUKIN_LEVELS_IN_THE_PATHOGENESIS_OF_CORONAVIRUS_INFECTION.pdf480.63 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.